Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11341727 | 0.96 | CYP2C19 (0.40) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL17355390 | 0.91 | CYP2C19 (0.41) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL16144553 | 0.90 | CYP2C19 (0.45) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL3972281 | 0.88 | CYP2C19 (0.43) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL10123924 | 0.86 | CYP2C19 (0.54) | CYP2C19CYP2C9MEN1KMT2ACYP1A2 | |
| SCHEMBL9079152 | 0.85 | CYP2C19 (0.41) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL24193268 | 0.84 | CYP2C19 (0.52) | CYP2C19CYP2C9MEN1KMT2ACYP1A2 | |
| SCHEMBL10123895 | 0.84 | CYP2C19 (0.52) | CYP2C19CYP2C9MEN1KMT2ACYP1A2 | |
| SCHEMBL22908466 | 0.84 | CYP2C19 (0.47) | CYP2C19CYP2C9MEN1KMT2AGLA | |
| SCHEMBL4192702 | 0.83 | CYP2C19 (0.39) | CYP2C19MEN1KMT2AGLACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2175709-B1 | SEED TREATMENT METHODS | BASF SE (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| US-20110257284-A1 | PROCESS FOR PRODUCING FLAME-RETARDANT PU FOAMS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110105333-A1 | Seed Treatment Compositions and Methods | BASF SE (DE) | 2011-05-05 | — | — | US | disclosed |
| EP-2308460-A1 | Composition comprising active agents and at least one nitrogen-containing hyper-branched polymer | BASF SE (DE) | 2011-04-13 | — | — | EP | disclosed |
| US-20090257960-A1 | NEUTRALIZED ACID GROUP-CONTAINING POLYMERS AND THE USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-10-15 | — | — | US | disclosed |
| EP-1773906-B1 | CROSS-LINKED POLYTETRAHYDROFURAN-CONTAINING POLYURETHANES | BASF SE (DE) | 2009-04-29 | — | — | EP | disclosed |
| US-20090081137-A1 | Crosslinked Polytetrahydrofuran-Containing Polyurethanes | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-26 | — | — | US | disclosed |
| EP-2023892-A1 | NEUTRALIZED ACID GROUP-CONTAINING POLYMERS AND THE USE THEREOF | BASF SE (DE) | 2009-02-18 | — | — | EP | disclosed |
| US-20090041813-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
| WO-2001016200-A1 | COSMETIC BASED ON OLIGOMERS AND POLYMERS CONTAINING URETHANE AND/OR UREA FUNCTIONAL GROUP | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-08 | — | — | WO | disclosed |
| US-5914072-A | DISPERSANTS FOR SOLIDS; FOR USE IN PAINTS, INKS | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-22 | — | — | US | disclosed |
| US-5863879-A | POLYMER IS FORMED BY REACTING A POLYMER CONTAINING VINYLAMINE UNIT WITH COMPOUNDS CONTAINING ALDEHYDE OR KETO GROUPS AND OPTIONAL OTHER AMINE OR ALOCHOL CONTAINING COMPOUNDS SUCH AS AMINAL, HEMIAMINAL OR AMINAL ACETATE | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |
| EP-0756618-B1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AG (DE) | 1998-08-12 | — | — | EP | disclosed |
| EP-0759440-A2 | Phosphoric acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1997-02-26 | — | — | EP | disclosed |
| EP-0756618-A1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-02-05 | — | — | EP | disclosed |
| WO-1995029221-A1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-02 | — | — | WO | disclosed |
| WO-1994024361-A1 | USE OF ALKOXYLATED POLYAMINES AND THEIR N-OXIDES, AS WELL AS THEIR PARTIAL AMIDES WITH CARBOXYLIC ACIDS, AS LEATHER DYEING AUXILIARY AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-27 | — | — | WO | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-3992307-A | BIS-PHOSPHORAMIDE | CHEVRON RESEARCH COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090081137-A1 | Crosslinked Polytetrahydrofuran-Containing Polyurethanes | PUF60, MACF1, FKBP5 | CYP2C19 312/4885CYP2C9 333/4885MEN1 3299/4885 |
| US-20110105333-A1 | Seed Treatment Compositions and Methods | PTK2, BROX, FYN | CYP2C19 3575/4885CYP2C9 4152/4885MEN1 4240/4885 |
| US-20090257960-A1 | NEUTRALIZED ACID GROUP-CONTAINING POLYMERS AND THE USE THEREOF | PARG, PUF60, PARN | CYP2C19 2844/4885CYP2C9 3410/4885MEN1 575/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | CYP2C19 4226/4885CYP2C9 4764/4885MEN1 1633/4885 |
| US-20090041813-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | CYP2C19 4226/4885CYP2C9 4764/4885MEN1 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.